Iberogast

Iberogast has a long history. It was researched and developed by scientists in the late 1950s, and first launched in Germany in the early 1960s. Iberogast has provided sufferers with fast-acting, effective relief for over 50 years and is now one of the leading gastrointestinal medicines in Germany and available in many countries of the world. The efficacy of Iberogast was studied in clinical trials and real-world evidence studies. In more than 20 projects, its efficacy in relieving symptoms of functional gastrointestinal disorders, such as irritable stomach (Functional Dyspepsia) and irritable bowel syndrome (IBS) was shown.